Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Redox regulation in cancer: a double-edged sword with therapeutic potential.

Acharya A, Das I, Chandhok D, Saha T.

Oxid Med Cell Longev. 2010 Jan-Feb;3(1):23-34. doi: 10.4161/oxim.3.1.10095. Review.

2.

Free radicals, metals and antioxidants in oxidative stress-induced cancer.

Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M.

Chem Biol Interact. 2006 Mar 10;160(1):1-40. Epub 2006 Jan 23. Review.

PMID:
16430879
3.

Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation.

Tian H, Gao Z, Wang G, Li H, Zheng J.

Tumour Biol. 2016 Jan;37(1):141-50. doi: 10.1007/s13277-015-4370-6. Epub 2015 Nov 13. Review.

PMID:
26566628
4.

The redox regulation of thiol dependent signaling pathways in cancer.

Giles GI.

Curr Pharm Des. 2006;12(34):4427-43. Review.

PMID:
17168752
5.

Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Bao B, Azmi AS, Li Y, Ahmad A, Ali S, Banerjee S, Kong D, Sarkar FH.

Curr Stem Cell Res Ther. 2014 Jan;9(1):22-35. Review.

6.

Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.

Cheng X, Ku CH, Siow RC.

Free Radic Biol Med. 2013 Sep;64:4-11. doi: 10.1016/j.freeradbiomed.2013.07.025. Epub 2013 Jul 21. Review.

PMID:
23880293
7.

Role of oxidative stress in cadmium toxicity and carcinogenesis.

Liu J, Qu W, Kadiiska MB.

Toxicol Appl Pharmacol. 2009 Aug 1;238(3):209-14. doi: 10.1016/j.taap.2009.01.029. Epub 2009 Feb 21. Review.

8.

Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy.

Marengo B, Nitti M, Furfaro AL, Colla R, Ciucis CD, Marinari UM, Pronzato MA, Traverso N, Domenicotti C.

Oxid Med Cell Longev. 2016;2016:6235641. doi: 10.1155/2016/6235641. Epub 2016 Jun 21. Review.

9.

Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.

Pathania D, Sechi M, Palomba M, Sanna V, Berrettini F, Sias A, Taheri L, Neamati N.

Biochim Biophys Acta. 2014 Jan;1840(1):332-43. doi: 10.1016/j.bbagen.2013.08.005. Epub 2013 Aug 15.

PMID:
23954204
10.

Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB.

Antioxid Redox Signal. 2012 Jun 1;16(11):1295-322. doi: 10.1089/ars.2011.4414. Epub 2012 Jan 16.

12.

Therapeutic strategies by modulating oxygen stress in cancer and inflammation.

Fang J, Seki T, Maeda H.

Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302. doi: 10.1016/j.addr.2009.02.005. Epub 2009 Feb 26. Review.

PMID:
19249331
13.

Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.

Zhang L, Li J, Zong L, Chen X, Chen K, Jiang Z, Nan L, Li X, Li W, Shan T, Ma Q, Ma Z.

Oxid Med Cell Longev. 2016;2016:1616781. doi: 10.1155/2016/1616781. Epub 2016 Jan 3. Review.

14.

BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.

Gorrini C, Baniasadi PS, Harris IS, Silvester J, Inoue S, Snow B, Joshi PA, Wakeham A, Molyneux SD, Martin B, Bouwman P, Cescon DW, Elia AJ, Winterton-Perks Z, Cruickshank J, Brenner D, Tseng A, Musgrave M, Berman HK, Khokha R, Jonkers J, Mak TW, Gauthier ML.

J Exp Med. 2013 Jul 29;210(8):1529-44. doi: 10.1084/jem.20121337. Epub 2013 Jul 15.

15.

The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.

Manna A, De Sarkar S, De S, Bauri AK, Chattopadhyay S, Chatterjee M.

Phytomedicine. 2015 Jul 15;22(7-8):713-23. doi: 10.1016/j.phymed.2015.05.007. Epub 2015 May 29.

PMID:
26141757
16.

Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis.

Acharya A, Das I, Singh S, Saha T.

Recent Pat Food Nutr Agric. 2010 Jun;2(2):166-77. Review.

PMID:
20653562
17.

Reactive oxygen species in redox cancer therapy.

Tong L, Chuang CC, Wu S, Zuo L.

Cancer Lett. 2015 Oct 10;367(1):18-25. doi: 10.1016/j.canlet.2015.07.008. Epub 2015 Jul 14. Review.

PMID:
26187782
18.

The redox biology network in cancer pathophysiology and therapeutics.

Manda G, Isvoranu G, Comanescu MV, Manea A, Debelec Butuner B, Korkmaz KS.

Redox Biol. 2015 Aug;5:347-57. doi: 10.1016/j.redox.2015.06.014. Epub 2015 Jun 25. Review.

19.

Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.

Gao L, Mann GE.

Cardiovasc Res. 2009 Apr 1;82(1):9-20. doi: 10.1093/cvr/cvp031. Epub 2009 Jan 29. Review.

PMID:
19179352
20.

Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells - up regulation of Nrf2 expression and down regulation of NF-κB and COX-2.

Ramyaa P, Krishnaswamy R, Padma VV.

Biochim Biophys Acta. 2014 Jan;1840(1):681-92. doi: 10.1016/j.bbagen.2013.10.024. Epub 2013 Oct 24.

PMID:
24161694

Supplemental Content

Support Center